TransMedics Group, Inc.

TransMedics is a medical technology company that develops systems and services for organ transplantation. Its core product platform is the Organ Care System, a portable warm perfusion device designed to preserve donor hearts, lungs, and livers in a functioning state outside the human body. The system comprises an electromechanical console, single-use perfusion sets, and nutrient solutions. The company also offers the National OCS Program, providing outsourced organ procurement, perfusion management, and air and ground transport logistics. Its primary customers are hospital transplant programs and academic medical centers.

The company is headquartered in Andover, Massachusetts, with plans to transition its headquarters to Somerville, Massachusetts. It maintains an aircraft maintenance hub in Dallas, Texas, and operates a fleet of 22 fixed-wing aircraft across the United States. Internationally, the company conducts research and development in Mirandola, Italy, and maintains distribution, commercial, and logistics operations in Europe. As of December 31, 2025, the company employed 898 people worldwide, the majority of whom were full-time personnel located in the United States.

Summary of the business section of TransMedics's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

“As of December 31, 2025, we employed 898 people globally, most of whom were full-time and located in the United States.”